1 September 2024

Starpharma Boardroom Radio Interview

Melbourne, Australia; Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is pleased to provide investors with the opportunity to listen to an audio interview with Chief Executive Officer Dr Jackie Fairley on Boardroom Radio (BRR).

 

Dr Fairley is discussing the Company’s recent announcement of preliminary analyses of the pharmacokinetics (PK) of DEP™ docetaxel from the ongoing Phase 1 human clinical trial and the imminent launch of the VivaGel® condom in Australia. 

 

The interview also refers to the status of other development programs at Starpharma, including VivaGel® for bacterial vaginosis.

 

To listen access via the below link, or copy the link into your web browser:

 

 http://www.brrmedia.com/event/127937

This contains certain forward-looking statements.

Important Notice

This website is intended for people seeking information about Starpharma for investment and business purposes. This website contains information about products that may not be available, or approved, in all countries, or may be available under different trademarks, or for different indications. Individuals seeking information about a Starpharma product should visit the relevant product website in their country of residence or consult a healthcare provider. Nothing contained on this site should be considered a solicitation, promotion, or advertisement for any product, including those under development. Any information on this site is not intended to provide medical advice nor should be used as a substitute for the advice provided by a doctor or other healthcare provider.